*A corporate client of Hybridan LLP


Dish of the day

No Joiners Today

Off the menu

No Leavers Today


What’s cooking in the IPO kitchen?

The pantry is bare!


Banquet Buffet

Europa Oil & Gas 1.3p  £5.8m (LON:EOG)

 Acquisition of offshore Ireland licence in proven gas play

Acquisition of licence near Corrib gas field in the Slyne Basin is in line with the refocus of Europa’s Irish portfolio towards gas

Includes 1.2 tcf Edge prospect which together with Europa’s nearby 1.5 tcf Inishkea prospect represents a strategic position in a proven gas play

Forward plan is to relaunch farm-out once acquisition has been approved by Irish authorities


Agronomics  7p  £23.2m (LON:ANIC)

The Company has co-led Meatable B.V.  Seed 2 financing round of approximately EUR6 million. As part of this round, Agronomics has invested EUR1 million for 997 Seed 2 Preferred Shares. The Subscription will be paid using cash from the Company’s own resources.

Richard Reed, Chairman of Agronomics commented: –

“The coronavirus has highlighted that the exploitation of animals for their meat could be a major risk for human health and perversely the stability of the food supply chains.  Our confidence is growing that Meatable is a clear differentiated player in the cultivated meat sector which has the potential to end up having a key role in addressing this risk along with the additional benefits to animal welfare and environmental sustainability.” Since Agronomics’ initial participation, Meatable has made strong technical progress, including producing both muscle and fat from its reprogrammed Opti-Ox porcine cells, and remains on target for its prototype in Q3 2020.


Greatland Gold 12.5p  £463m (LON:GGP)

Newcrest Reports Further Outstanding Drill Results from Havieron. 

Initial step out drilling intersects significant mineralisation 220m north west of previous intersections ( 82.1m @ 2.4 g/t Au, 0.08% Cu from 557.6m, HAD066). 

Multiple exceptional results from infill drilling, including 109m @ 6.3g/t Au, 0.71% Cu from 668m (HAD059).


Diaceutics 150p  £104m (LON:DXRX)

£20.5m conditional placing at 145p.   Proceeds of the Placing will strengthen the balance sheet in readiness for new growth opportunities:

o  Rapid market growth will require additional resource

o  Integration of new data insights beyond oncology

o  Diaceutics on track to launch ‘DXRX – The Diagnostic Network™’ (“DXRX”), its unique digital platform in Q4 2020

o  DXRX can capture more of the diagnostic commercialisation value chain through the development of new data and service modules


Faron Pharma 340p  £159.12m (LON:FARN)

The clinical stage biopharmaceutical company, announces today that, it has been selected to receive a EUR2.5 million grant from the European Innovation Council (EIC) Accelerator pilot scheme to progress the MATINS Study and related business activities.

Faron’s ongoing phase I/II MATINS clinical trial is investigating the tolerability, safety and efficacy of Clevegen, the Company’s wholly-owned novel precision cancer immunotherapy targeting Clever-1 positive tumour associated macrophages (TAM), in selected metastatic or inoperable solid tumours.


Cohort 563p  £231m (LON:CHRT)

Wholly owned subsidiary, Chess Dynamics , has been awarded a EUR7.5 million contract for its Air Guard Counter-Unmanned Aerial Systems (C-UAS) for air base and critical infrastructure protection for an international customer.  The majority of the contract is to be delivered during the current and next financial years.


Open Orphan 11.9p  £70.6m (LON:ORPH)

The Company has signed a major contract with a leading vaccine developer and one of the top pharmaceutical companies in the world.

The contract with Venn Life Sciences, which is part of Open Orphan, builds on earlier successful contracts between the companies and is to obtain and support market access of newly developed vaccines into the EU and US markets until the end of 2020.


Inspiration Health  66.5p  £25.5m (LON:IHC)

“Project Wave” which is developing a novel technology for a respiratory device designed to be used in neonatal intensive care has been awarded a grant towards the cost of trials expected to commence this year on 20 babies at Trevor Mann Unit, Brighton & Sussex University Hospital.   

The Med Tech Trials Innovation Support Grant (MTT-ISG) has been awarded by the Academic Health Science Networks (AHSN) and part financed by the European Regional Development Fund (ERDF) will contribute up to 50% (£50,000 maximum) towards the costs of the trials.


Angling Direct 51p  £33m (LON:ANG)

The largest specialist fishing tackle and equipment retailer in the UK, today announces a proposed Placing of new ordinary shares in the Company to raise gross proceeds  of approximately £5.50 million at not less than 50p per share.

The net proceeds of the Placing will strengthen the Group’s balance sheet to provide further protection against the uncertainty created by Covid-19 and provide additional funding for prompt payment of suppliers to secure product, given the high level of customer demand anticipated over the coming weeks as lock-down restrictions are eased and retail stores re-open from 15 June 2020 (which coincides with the start of the coarse fishing season). At a time when greater certainty exists, the Board anticipates that the Company will allocate any surplus funds from the Placing to growth opportunities.


Coinsilium 2.45p  £3.33m (AQSE:COIN)

Coinsilium is organising, jointly with portfolio company Indorse  Pte. Ltd. (“Indorse”) the ‘Post Covid Hack’ a global online blockchain  hackathon from July to October 2020.


A Hackathon is a design sprint-like event in which computer programmers and software developers collaborate intensively on software projects with the goal of creating functioning software solutions by the end of the event. Online hackathons are usually spread over several weeks, allowing teams to join later in the process whilst leaving them with more time to build more advanced solutions.